Three months in, the scale stops moving. You’re still injecting, still tracking calories, still doing the things that worked in weeks two through eight. Nothing. That’s the plateau moment, and it’s where most programs either earn their fee or quietly fail you. I’ve spent time comparing what’s actually available in 2026, and these eight made the cut.
1. HealthRX
If price is the reason you’ve been putting this off, HealthRX removes that argument. Compounded semaglutide starts at $99 per month, tirzepatide at $149. Those are some of the lowest posted cash prices I’ve seen from any telehealth provider with a named, verifiable pharmacy behind it. Manifest Pharmacy in Greer, South Carolina handles dispensing. It’s a 503A/USP-797 facility with lot tracking from production to your door, and it carries LegitScript certification (cert 50087439). You fill out a health assessment, a US board-certified physician reviews it within roughly 24 hours, and medication ships overnight to all 50 states for free. No surprise fees on the invoice.
The trial data HealthRX points to: tirzepatide produced roughly 21% average body weight loss at 72 weeks in SURMOUNT-1; semaglutide roughly 15% at 68 weeks in STEP 1. These are published clinical results, not HealthRX’s own outcomes. Compounded medications are not FDA-approved, so that context matters.
Best for: Cash-pay patients who want a verified pharmacy, fast turnaround, and the lowest entry price across GLP-1 options.
Pro: Named, 503A-certified pharmacy plus all-50-states overnight shipping at a price point most telehealth brands can’t touch.
Con: Compounded GLP-1s are not FDA-approved, and monitoring is lighter than premium programs like Form Health.
2. FormBlends
FormBlends sits in an interesting position. It’s a compounded GLP-1 telehealth provider with physician oversight, dispensing through an FDA-registered 503A compounding pharmacy, and it publishes per-product purity testing: HPLC purity percentages, mass spec identity confirmation, endotoxin and sterility results, with named numbers rather than vague quality claims. That’s genuinely unusual. Most GLP-1 telehealth brands mention quality control without showing you the data.
Cash pricing runs higher than HealthRX: around $299 per vial for semaglutide and $349 for tirzepatide. FormBlends also ships to 47 states (not all 50), and it carries a wide peptide catalog covering recovery, longevity, and cognitive peptides, all under the same clinician model. If you want GLP-1 treatment alongside other peptide therapies from one provider, this is one of the very few places structured for that.
Best for: Buyers who want published purity documentation, or who plan to combine GLP-1s with other peptide protocols.
Pro: Transparent, published lab testing on each product, which is a real differentiator in a crowded compounding market.
Con: Per-vial pricing is meaningfully higher than HealthRX, and coverage excludes three states.
3. Mochi Health
Mochi uses board-certified obesity-medicine physicians, not general practitioners. That matters at a plateau because someone trained specifically in metabolic medicine is more likely to adjust your dose or switch medications rather than just telling you to be patient. Monthly costs come in around $99 for compounded semaglutide and $199 for tirzepatide. Monitoring is heavier than at cash-pay-only competitors.
Best for: Patients who want obesity-medicine specialists and don’t mind paying more for the tirzepatide tier.
Pro: Clinician quality above average for the price range.
Con: Tirzepatide cost climbs noticeably compared to semaglutide tier.
4. Ro Body
Ro‘s prior-authorization team is the real selling point. They’ll work to get branded medications covered through your insurance, which can change the math entirely. First month membership is around $39, then roughly $74 to $149 per month, with medications billed separately. For anyone with insurance that might cover Wegovy or Zepbound, Ro is worth the call.
Best for: Insured patients willing to do the paperwork for potential branded-med coverage.
Pro: Active prior-auth support is something most telehealth platforms skip entirely.
Con: Medication cost sits on top of the membership, so cash-pay totals add up fast.
5. Hims & Hers
After the March 2026 Novo Nordisk settlement, Hims & Hers shifted away from compounded semaglutide toward branded medications. Injectable Wegovy is listed around $299 per month, oral semaglutide around $249, and Zepbound around $399. With insurance plus a savings card, some members bring that to nearly nothing. Big platform, lots of support content. The brand recognition here is real.
Best for: Patients who specifically want branded GLP-1s through a polished, well-supported app experience.
Pro: Savings card stacking with insurance can produce dramatic out-of-pocket reductions.
Con: Without insurance, pricing is among the higher end on this list.
6. Found
Found charges roughly $99 per month for platform access plus medication costs on top. The coaching layer is more structured than most telehealth platforms, and they address behavioral patterns alongside the prescription, which matters for long-term plateau breaking. Not just medication, actual habit work.
Best for: People who want coaching woven into their program, not just a prescription.
Pro: Behavioral component is more developed than pure prescription platforms.
Con: Total monthly cost once you add medications climbs well past the platform fee.
7. Form Health
Form Health assigns both a physician and a registered dietitian to each patient. That combination is rare and expensive: around $299 per month for the program, plus labs, plus medication costs. For someone who has plateaued repeatedly and suspects the issue is nutritional rather than purely pharmacological, having an actual dietitian reviewing your intake weekly is worth considering.
Best for: Patients with complex histories who want the most supervised option available.
Pro: MD plus dietitian pairing is the most thorough clinical model on this list.
Con: One of the most expensive options, and not built for budget-conscious buyers.
8. PlushCare
PlushCare is general telehealth that includes weight management. Membership runs around $19.99 per month, same-day visits are often available, and they work with insurance on branded medications. It’s the most accessible entry point here, though it lacks the obesity-medicine specialization of Mochi or the pharmacy transparency of HealthRX and FormBlends.
Best for: Someone who wants a fast, low-cost visit and already has insurance that covers GLP-1 medications.
Pro: Lowest membership fee on the list, with same-day availability.
Con: General-practice model means less specialization in plateau management specifically.
A Quick Note on Compounded Medications
Several programs above dispense compounded GLP-1 medications. These are not FDA-approved. In early 2026, the FDA sent warning letters to upward of 30 telehealth platforms and compounding operations. Pharmacy credentials (503A status, named facilities, LegitScript certification, published purity testing) matter more now than they did two years ago. Ask before you order.
Common Questions
When a plateau hits on semaglutide, does switching to tirzepatide actually help?
It can. Tirzepatide activates both GIP and GLP-1 receptors, while semaglutide targets GLP-1 alone. Some patients who stall on semaglutide respond to the switch, though individual results vary and the decision should involve a physician, ideally one with obesity-medicine training like those at Mochi Health.
What makes HealthRX’s pharmacy credentials worth paying attention to compared with other low-cost GLP-1 providers?
Most budget telehealth platforms don’t name their compounding pharmacy at all. HealthRX publicly identifies Manifest Pharmacy, its 503A/USP-797 status, and a specific LegitScript certification number. That traceability is verifiable, which matters given the FDA’s 2026 warning letters to dozens of compounding operations.
Does Form Health’s dietitian pairing actually change plateau outcomes, or is it just a premium add-on?
Plateaus are sometimes pharmacological and sometimes nutritional. A registered dietitian reviewing weekly intake can catch patterns a physician won’t, such as caloric creep or protein undereating that blunts results. At $299 per month before medications, it’s expensive, but it’s the only program here built to address both sides at once.
If I have insurance, which of these programs gives me the best shot at getting Wegovy or Zepbound covered without paying full price?
Ro Body is the clearest answer. Their prior-authorization team actively works insurance on your behalf, which most platforms skip. Hims & Hers is also worth considering if your insurer covers branded GLP-1s, since savings card stacking can reduce out-of-pocket costs significantly.
Does FormBlends’ published purity testing actually mean the medication is stronger or safer than competitors?
Not necessarily stronger. What it means is you can see the HPLC purity percentage, mass spec confirmation, and sterility results for the specific product you’re buying, rather than taking quality on faith. That transparency doesn’t guarantee outcomes, but it does let you verify what you’re getting in a way most GLP-1 telehealth brands don’t allow.
Sources
- FDA: Compounding and the FDA, 503A oversight guidance (FDA.gov)
- SURMOUNT-1 trial: Jastreboff et al., New England Journal of Medicine, 2022
- STEP 1 trial: Wilding et al., New England Journal of Medicine, 2021
- Novo Nordisk/compounding settlement reporting: Reuters, STAT News, March 2026
- LegitScript certification database (LegitScript.com)
- Lilly Direct orforglipron pricing: Eli Lilly press release, April 2026